Regen BioPharma Inc (OTCPK:RGBP)
$ 1.05 -0.05 (-4.55%) Market Cap: 4.32 Mil Enterprise Value: 5.14 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Regen BioPharma Inc At Emerging Growth Conferenece Transcript

Feb 22, 2023 / 07:40PM GMT
Release Date Price: $2.85 (-5.00%)
Ana Berry
Berry Media, Inc. - Moderator

Welcome back, everyone. Next up, we have Regen BioPharma Inc. It trades on the OTC pink sheets under the symbol RGBP and RGBPP. Focused on the immunology and immunotherapy space, this company has focused on rapidly advancing novel technologies through preclinical and Phase 1 and 2 clinical trials. Currently, the company has focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Please welcome its President and CEO, David Koos, with Senior Scientific Consultant, Harry Lander. Welcome back, gentlemen.

David Koos
Regen BioPharma, Inc. - CEO, President & Chairman

Well, thank you, Ana, and we're happy to be here and looking forward to addressing any questions and issues that shareholders may have.

Ana Berry
Berry Media, Inc. - Moderator

Right.

Questions & Answers

David Koos
Regen BioPharma, Inc. - CEO, President & Chairman

And with that, I'll start off with no particular order.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot